Cancer and multiple sclerosis patients insured by Medicare are among those awaiting lower drug prices from the Inflation Reduction Act.
from USATODAY - News Top Stories https://ift.tt/YKHtMr0
via IFTTT
Tuesday, September 6, 2022
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
from USATODAY - News Top Stories https://ift.tt/YKHtMr0
via IFTTT
0 comments:
Post a Comment